Literature DB >> 2330087

Use of Vicryl (polyglactin 910) mesh to limit epidural scar formation after laminectomy.

C E Nussbaum1, J V McDonald, R B Baggs.   

Abstract

A variety of substances have been used at laminectomy sites to prevent postoperative epidural scarring. Free grafts of autologous subcutaneous fat are commonly used both clinically and experimentally. The free fat grafts usually survive, but decrease in size by about 50%. Postoperatively, subcutaneous seroma has been observed with the use of fat grafts, as well as recurrent symptoms of neural compression by the graft that required additional operations. When compared to the use of free grafts after laminectomy in dogs, Vicryl mesh produced slightly more scarring, but consistently less than that observed in control animals. The Vicryl mesh was resorbed by a minimal chronic inflammatory response over about 45 days. Seven of 11 fat-grafted zones showed signs of necrosis, at times with a greater collection of inflammatory cells than that associated with the Vicryl mesh. Of the 4 fat-grafted zones that showed good survival, 2 had gross evidence of neural compression. No surgical zone treated with Vicryl mesh exhibited evidence of neural compression. In view of these results, the use of Vicryl mesh at laminectomy sites may be a safer method of limiting postoperative epidural scar formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330087     DOI: 10.1097/00006123-199004000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

1.  The effect of epidural free fat graft on the outcome of lumbar disc surgery.

Authors:  Aşkin Görgülü; Osman Simşek; Sabahattin Cobanoğlu; Murat Imer; Turgay Parsak
Journal:  Neurosurg Rev       Date:  2003-10-08       Impact factor: 3.042

2.  Effect of fibrin glue on postlaminectomy scar formation.

Authors:  J Vaquero; A Arias; S Oya; R Martinez; M Zurita
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  Epidural scar tissue formation after spinal surgery: an experimental study.

Authors:  J Pospiech; F Pajonk; D Stolke
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

4.  Mitomycin C, 5-fluorouracil, and cyclosporin A prevent epidural fibrosis in an experimental laminectomy model.

Authors:  Kartal Hakan Yildiz; Ferruh Gezen; Merih Is; Selma Cukur; Murat Dosoglu
Journal:  Eur Spine J       Date:  2007-03-27       Impact factor: 3.134

5.  The role of closed-suction drainage in preventing epidural fibrosis and its correlation with a new grading system of epidural fibrosis on the basis of MRI.

Authors:  Orhan Sen; Osman Kizilkilic; M Volkan Aydin; Ozlem Yalcin; Bulent Erdogan; Melih Cekinmez; Hakan Caner; Nur Altinors
Journal:  Eur Spine J       Date:  2004-11-04       Impact factor: 3.134

6.  [The scar tissue protective effect of free autologous fatty tissue transplants. An animal experiment on spinal surgery].

Authors:  J Pospiech; R Kalff; F Pajonk; D Stolke; V Reinhardt
Journal:  Langenbecks Arch Chir       Date:  1994

7.  Evaluation of Perivascular Adhesion Formation in New Zealand White Rabbits Using Oxiplex and DuraSeal Xact Adhesion Barrier System.

Authors:  Fred Mo; James Yue; Jianghui Zhang; Kreg Howk; Allister Williams
Journal:  SAS J       Date:  2009-06-01

8.  A novel controlled release tetrandrine-loaded PDLLA film: evaluation of drug release and anti-adhesion effects in vitro and in vivo.

Authors:  Hai Yao; Zhidong Cao; Lei Peng; Jian Liu; Xiaoxing Zhang; Zhilong Deng
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

9.  Tumor necrosis factor-α blockade in recurrent and disabling chronic sciatica associated with post-operative peridural lumbar fibrosis: results of a double-blind, placebo randomized controlled study.

Authors:  Christelle Nguyen; Clémence Palazzo; Sophie Grabar; Antoine Feydy; Katherine Sanchez; Nathalie Zee; Laurent Quinquis; Myriam Ben Boutieb; Michel Revel; Marie-Martine Lefèvre-Colau; Serge Poiraudeau; François Rannou
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.